After putting Roche through multiple delays during a 10-month review, the FTC has determined that Roche isn’t spending $4.3 billion to buy Spark so it can destroy a potential competitor, or use it to replace one of their new blockbusters. And the pharma giant followed up soon after to say
A CDC advisory panel voted to recommend RSV vaccines for at-risk adults 50 to 59, a sought-after expansion by vaccine makers who are trying to…
A panel of experts who decide the national immunization schedule will meet on Tuesday for the first time in 2025, providing an opportunity for the…
Get the latest news on President Donald Trump’s return to the White House and the new Congress.
An already bleak biotech market has become more daunting for job seekers, particularly executives.
SAN FRANCISCO, April 10, 2025 – The Parker Institute for Cancer Immunotherapy (PICI), a collaborative consortium of the world’s leading immuno-oncology experts that bridges scientific…
It is the second confirmed measles death in the U.S. in a decade. If the outbreak continues at the current pace, the nation may lose…
The financial titans who backed Trump are now dealing with the fallout from his tariffs. They spent the weekend surveying the damage of last week’s…
It is the second confirmed measles death in the U.S. in a decade. If the outbreak continues at the current pace, the nation may lose…
It is the second confirmed measles death in the U.S. in a decade. If the outbreak continues at the current pace, the nation may lose…
On the precipice of FDA approval, Novavax’s Covid vaccine is now in limbo while a decision to approve or reject it is held up.
